FDA Inspection
The Blood CenterThe Blood Center – FDA Inspection, Jun 29, 2017
Record Details
This FDA Inspection record concerns The Blood Center, with an inspection on June 29, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 14e3bb82-1877-4b65-87df-b1e08f1ddf5f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1016227
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 606.171Biological product deviation report
- 21 CFR 606.160(a)(1)Concurrent documentation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of The Blood Center
8| Date | Classification | Office | Project area |
|---|---|---|---|
| August 16, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 17, 2022 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 17, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 16, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| December 11, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for The Blood Center
- FDA Inspection 1229822 - 2024-08-16
- FDA Inspection 1172118 - 2022-06-17
- FDA Inspection 1088614 - 2019-04-17
- FDA Inspection 935002 - 2015-07-16
- FDA Inspection 907001 - 2014-12-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.